<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Age Ageing</journal-id><journal-id journal-id-type="iso-abbrev">Age Ageing</journal-id><journal-id journal-id-type="pmc-domain-id">709</journal-id><journal-id journal-id-type="pmc-domain">ageing</journal-id><journal-id journal-id-type="publisher-id">ageing</journal-id><journal-title-group><journal-title>Age and Ageing</journal-title></journal-title-group><issn pub-type="ppub">0002-0729</issn><issn pub-type="epub">1468-2834</issn><publisher><publisher-name>Oxford University Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC10945292</article-id><article-id pub-id-type="pmcid-ver">PMC10945292.1</article-id><article-id pub-id-type="pmcaid">10945292</article-id><article-id pub-id-type="pmcaiid">10945292</article-id><article-id pub-id-type="pmid">38497237</article-id><article-id pub-id-type="doi">10.1093/ageing/afae047</article-id><article-id pub-id-type="publisher-id">afae047</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Research Paper</subject></subj-group><subj-group subj-group-type="category-taxonomy-collection"><subject>AcademicSubjects/MED00280</subject><subject>ageing/7</subject><subject>ageing/17</subject></subj-group></article-categories><title-group><article-title>Short- and long-term safety of discontinuing chronic opioid therapy among older adults with Alzheimer&#8217;s disease and related dementia</article-title></title-group><contrib-group><contrib contrib-type="author" corresp="yes"><contrib-id contrib-id-type="orcid" authenticated="false">https://orcid.org/0000-0001-8861-6907</contrib-id><name name-style="western"><surname>Wei</surname><given-names initials="YJJ">Yu-Jung Jenny</given-names></name><aff>
<institution>Division of Outcomes and Translational Sciences, College of Pharmacy, The Ohio State University</institution>, <addr-line>Columbus, OH 43210</addr-line>, <country country="US">USA</country></aff><xref rid="cor1" ref-type="corresp"/></contrib><contrib contrib-type="author"><name name-style="western"><surname>Winterstein</surname><given-names initials="AG">Almut G</given-names></name><aff>
<institution>Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida</institution>, <addr-line>Gainesville, FL 32610</addr-line>, <country country="US">USA</country></aff><aff>
<institution>Center for Drug Evaluation and Safety, University of Florida</institution>, <addr-line>Gainesville, FL 32610</addr-line>, <country country="US">USA</country></aff><aff>
<institution>Department of Epidemiology, Colleges of Medicine and Public Health and Health Professions, University of Florida</institution>, <addr-line>Gainesville, FL 32610</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schmidt</surname><given-names initials="S">Siegfried</given-names></name><aff>
<institution>Department of Community Health and Family Medicine, College of Medicine, University of Florida</institution>, <addr-line>Gainesville, FL 32610</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Fillingim</surname><given-names initials="RB">Roger B</given-names></name><aff>
<institution>Pain Research and Intervention Center of Excellence, University of Florida</institution>, <addr-line>Gainesville, FL</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Schmidt</surname><given-names initials="S">Stephan</given-names></name><aff>
<institution>Department of Pharmaceutics, College of Pharmacy, University of Florida</institution>, <addr-line>Gainesville, FL 32610</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>Daniels</surname><given-names initials="MJ">Michael J</given-names></name><aff>
<institution>Department of Statistics, College of Liberal Arts and Sciences, University of Florida</institution>, <addr-line>Gainesville FL, 32610</addr-line>, <country country="US">USA</country></aff></contrib><contrib contrib-type="author"><name name-style="western"><surname>DeKosky</surname><given-names initials="ST">Steven T</given-names></name><aff>
<institution>Department of Neurology, McKnight Brain Institute, University of Florida</institution>, <addr-line>Gainesville, FL 32610</addr-line>, <country country="US">USA</country></aff></contrib></contrib-group><author-notes><corresp id="cor1">Address correspondence to: Yu-Jung Jenny Wei, Tel: <phone>(+1) 614 247 9765</phone>. Email: <email>wei.1342@osu.edu</email></corresp></author-notes><pub-date pub-type="collection"><month>3</month><year>2024</year></pub-date><pub-date pub-type="epub" iso-8601-date="2024-03-15"><day>15</day><month>3</month><year>2024</year></pub-date><volume>53</volume><issue>3</issue><issue-id pub-id-type="pmc-issue-id">457400</issue-id><elocation-id>afae047</elocation-id><history><date date-type="received"><day>21</day><month>6</month><year>2023</year></date><date date-type="rev-request"><day>19</day><month>1</month><year>2024</year></date></history><pub-history><event event-type="pmc-release"><date><day>15</day><month>03</month><year>2025</year></date></event><event event-type="pmc-live"><date><day>15</day><month>03</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-03-15 00:25:32.953"><day>15</day><month>03</month><year>2025</year></date></event></pub-history><permissions><copyright-statement>&#169; The Author(s) 2024. Published by Oxford University Press on behalf of the British Geriatrics Society. All rights reserved. For permissions, please email: journals.permissions@oup.com</copyright-statement><copyright-year>2024</copyright-year><license><ali:license_ref>https://academic.oup.com/pages/standard-publication-reuse-rights</ali:license_ref><license-p>This article is published and distributed under the terms of the Oxford University Press, Standard Journals Publication Model (<ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="https://academic.oup.com/pages/standard-publication-reuse-rights">https://academic.oup.com/pages/standard-publication-reuse-rights</ext-link>)</license-p></license></permissions><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="afae047.pdf"/><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" xlink:href="afae047.pdf"/><abstract><title>Abstract</title><sec id="abs1"><title>Background</title><p>Limited evidence exists on the short- and long-term safety of discontinuing versus continuing chronic opioid therapy (COT) among patients with Alzheimer&#8217;s disease and related dementias (ADRD).</p></sec><sec id="abs2"><title>Methods</title><p>This cohort study was conducted among 162,677 older residents with ADRD and receipt of COT using a 100% Medicare nursing home sample. Discontinuation of COT was defined as no opioid refills for &#8805;90&#160;days. Primary outcomes were rates of pain-related hospitalisation, pain-related emergency department visit, injury, opioid use disorder (OUD) and opioid overdose (OD) measured by diagnosis codes at quarterly intervals during 1- and 2-year follow-ups. Poisson regression models were fit using generalised estimating equations with inverse probability of treatment weights to model quarterly outcome rates between residents who discontinued versus continued COT.</p></sec><sec id="abs3"><title>Results</title><p>The study sample consisted of 218,040 resident episodes with COT; of these episodes, 180,916 residents (83%) continued COT, whereas 37,124 residents (17%) subsequently discontinued COT. Discontinuing (vs. continuing) COT was associated with higher rates of all outcomes in the first quarter, but these associations attenuated over time. The adjusted rates of injury, OUD and OD were 0, 69 and 60% lower at the 1-year follow-up and 11, 81 and 79% lower at the 2-year follow-up, respectively, for residents who discontinued versus continued COT, with no difference in the adjusted rates of pain-related hospitalisations or emergency department visits.</p></sec><sec id="abs4"><title>Conclusions</title><p>The rates of adverse outcomes were higher in the first quarter but lower or non-differential at 1-year and 2-year follow-ups between COT discontinuers versus continuers among older residents with ADRD.</p></sec></abstract><kwd-group><kwd>long-term opioid therapy</kwd><kwd>nursing home</kwd><kwd>Alzheimer&#8217;s disease and related dementia</kwd><kwd>opioid-related adverse events</kwd><kwd>older people</kwd></kwd-group><funding-group><award-group award-type="grant"><funding-source><institution-wrap><institution>National Institute on Aging</institution><institution-id institution-id-type="DOI">10.13039/100000049</institution-id></institution-wrap></funding-source><award-id>R01AG073442</award-id></award-group></funding-group><counts><page-count count="12"/></counts><custom-meta-group><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>0</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>yes</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>